Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)

Clinical trial NCT04268706 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04268706
Sponsor: Tessa Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma, Adult Hodgkin Disease Recurrent Hodgkin Disease Refractory Hodgkin Disease, Pediatric

Start date: 2021-02-01
Primary completion: 2025-05-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.